A Study of LY3039478 in Japanese Participants With Advanced Solid Tumors

NCT02836600 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

11

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: LY3039478

Sponsor

Eli Lilly and Company